TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1424202

Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (40 mg daily for 3 months)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 2412054

Group type: EXPERIMENTAL
Intervention: Ketanserin given intravenously for seven days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Specific serotonergic antagonists (oral or intravenous)
Number of subjects: 0
Study: 31550800

Group type: COMPARATOR
Intervention: Serum D-dimer levels before delivery
Number of subjects: 785

Group type: COMPARATOR
Intervention: Serum D-dimer levels after delivery
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Postnatal serum D-dimer levels in AMAs
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Diagnosis of VTE
Number of subjects: 785
Study: 27817128

Group type: EXPERIMENTAL
Intervention: L-arginine with vitamins B6, folic acid and B12 (Telcor® Arginin plus)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 27567810

Group type: EXPERIMENTAL
Intervention: Active 'on' bilateral DBS directed at the fornix
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham 'off' bilateral DBS
Number of subjects: 42
Study: 24752034

Group type: EXPERIMENTAL
Intervention: Motive-oriented therapeutic relationship (MOTR) added to general psychiatric management (GPM) treatment
Number of subjects: 85

Group type: COMPARATOR
Intervention: General psychiatric management (GPM) treatment
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Motive-oriented therapeutic relationship (MOTR)
Number of subjects: 85
Study: 22759549

Group type: EXPERIMENTAL
Intervention: 2% Chlorhexidine gluconate (CHG) applied thrice-weekly
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control (Comfort Bath; Sage) cloths
Number of subjects: 77
Study: 20454851

Group type: EXPERIMENTAL
Intervention: IgPro20 (20% liquid SCIG) administered weekly
Number of subjects: 49
Study: 16858017

Group type: EXPERIMENTAL
Intervention: Light touch (LT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No touch (NT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Force touch (FT)
Number of subjects: 40
Study: 15616024

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous leisure-time physical activity (LTPA)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Strenuous, structured leisure-time physical activity (LTPA)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Total leisure-time physical activity (LTPA)
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Low-intensity and lifestyle leisure-time physical activity (LTPA)
Number of subjects: 487
Study: 12030952

Group type: EXPERIMENTAL
Intervention: Oral beclometasone dipropionate (BDP) 5 mg/day plus 5‐ASA 3.2 g/day
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo plus 5‐ASA 3.2 g/day
Number of subjects: 119
Study: 10080457

Group type: EXPERIMENTAL
Intervention: ACE inhibitor therapy
Number of subjects: 15104
Study: 7552537

Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin 750 mg x 2 p.o.
Number of subjects: 580

Group type: COMPARATOR
Intervention: Intravenous cefuroxime 1.5 g x 3 i.v. on the day of surgery
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 580
Study: 1310566

Group type: EXPERIMENTAL
Intervention: 15 g of WSDF/day consisting of psyllium husk, pectin, and guar and locust bean gums for 4 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10 g of WSDF/day from high-viscosity guar gum for 4 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5 g of WSDF/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 15 g of WSDF/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6370619

Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Metaproterenol
Number of subjects: 21

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 21
Study: 31561129

Group type: COMPARATOR
Intervention: Elective repeat caesarean section (ERCS)
Number of subjects: 862

Group type: EXPERIMENTAL
Intervention: Vaginal birth after caesarean (VBAC)
Number of subjects: 862

Group type: EXPERIMENTAL
Intervention: Poor antenatal HRQoL scores
Number of subjects: 862

Group type: EXPERIMENTAL
Intervention: Maternal readmission postpartum
Number of subjects: 862
Study: 30156470

Group type: EXPERIMENTAL
Intervention: RMD method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cochrane conversion method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SMD method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness model
Number of subjects: 0
Study: 27056644

Group type: EXPERIMENTAL
Intervention: Baseline weaker leg strength
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Trunk extensor endurance
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Slower leg velocity
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Restricted knee flexion motion
Number of subjects: 391
Study: 25534692

Group type: EXPERIMENTAL
Intervention: Cordless handpiece (HP-C)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Corded handpiece (HP-A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Corded handpiece (HP-B)
Number of subjects: 30
Study: 22759841

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 401

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 401
Study: 20456060

Group type: EXPERIMENTAL
Intervention: 3 : 1 mixture of propofol 1% and thiopental 2.5%
Number of subjects: 164

Group type: COMPARATOR
Intervention: 11 : 1 mixture of propofol and 2% lidocaine
Number of subjects: 164
Study: 17105779

Group type: EXPERIMENTAL
Intervention: Eligibility criteria for major asthma RCTs
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Eligibility criteria for major asthma RCTs (on treatment)
Number of subjects: 179
Study: 16366758

Group type: EXPERIMENTAL
Intervention: venlafaxine (150 to 225 mg daily, titrated based on symptoms) + behavioral counseling + transdermal nicotine replacement therapy (22 mg/day)
Number of subjects: 147

Group type: COMPARATOR
Intervention: placebo + behavioral counseling + transdermal nicotine replacement therapy (22 mg/day)
Number of subjects: 147
Study: 12095119

Group type: EXPERIMENTAL
Intervention: Immediate postoperative prosthesis (IPOP)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard soft dressings (Control)
Number of subjects: 19
Study: 10199535

Group type: EXPERIMENTAL
Intervention: Neutrophil function capacity assay measuring CD10 expression after stimulation with Staphylococcus aureus
Number of subjects: 30
Study: 7546831

Group type: EXPERIMENTAL
Intervention: Serotonin antagonists (ondansetron, granisetron, tropisetron)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Addition of steroids and dopamine D2 antagonist metopimazine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 2270825

Group type: EXPERIMENTAL
Intervention: Videotape presentations followed by classroom discussion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Extended classroom discussions
Number of subjects: 20
Study: 7011085

Group type: EXPERIMENTAL
Intervention: 0.4 mg/kg of hydrallazine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20
Study: 31508798

Group type: EXPERIMENTAL
Intervention: Individualized exercise training and behavioral change enhancement (BCE) program for 16 weeks with two booster sessions at 2 and 6 months after the program.
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Exercise training and health talks only for 16 weeks.
Number of subjects: 285

Group type: COMPARATOR
Intervention: Health talks only.
Number of subjects: 285
Study: 28283340

Group type: EXPERIMENTAL
Intervention: IV push low dose ketamine (0.3 mg/kg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Short infusion low dose ketamine (0.3 mg/kg)
Number of subjects: 48
Study: 27009433

Group type: EXPERIMENTAL
Intervention: Geneva cocktail (combination of low‐dose caffeine, flurbiprofen, omeprazole, dextromethorphan, midazolam, fexofenadine, bupropion)
Number of subjects: 30

Group type: COMPARATOR
Intervention: CYP probes administered alone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Geneva cocktail
Number of subjects: 30
Study: 25080037

Group type: EXPERIMENTAL
Intervention: Test implant (4.5-mm-diameter moderately roughened implant with a rounded 6-mm abutment)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control implant (3.75-mm diameter as-machined implant with a conically shaped 5.5-mm abutment)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Test implant
Number of subjects: 77
Study: 21826454

Group type: EXPERIMENTAL
Intervention: High-intensity sprint fatigue after running RS
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: High-intensity sprint fatigue after cycling RS
Number of subjects: 11
Study: 19309367

Group type: EXPERIMENTAL
Intervention: Long-pulsed dye laser (LPDL) treatment (V‐beam Perfecta, 595 nm)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Intense pulsed light (IPL) treatment (Ellipse Flex)
Number of subjects: 13
Study: 17311692

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with paclitaxel (200 mg/m2) and carboplatin (AUC 6) followed by observation
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with paclitaxel (200 mg/m2) and carboplatin (AUC 6) followed by radiation therapy (RT) at 5000 cGy in 25 fractions over 5 weeks
Number of subjects: 37
Study: 15206988

Group type: EXPERIMENTAL
Intervention: 1000 mg fosfluconazole once daily for 14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: 800 mg fluconazole once daily for 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 500 mg fosfluconazole once daily for 10 days (no loading dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loading dose of 1000 mg on day 1 followed by 500 mg for 9 days (one loading dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loading doses of 1000 mg on days 1 and 2 followed by 500 mg for 8 days (two loading doses)
Number of subjects: 0
Study: 11207642

Group type: EXPERIMENTAL
Intervention: Melatonin (1 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 9740522

Group type: EXPERIMENTAL
Intervention: Peritoneum open (n=21)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Peritoneum closed (n=19)
Number of subjects: 40
Study: 7952555

Group type: EXPERIMENTAL
Intervention: Lung sound mapping and time‐expanded wave‐form analysis in IPF
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Lung sound mapping and time‐expanded wave‐form analysis in CHF
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Lung sound mapping and time‐expanded wave‐form analysis in COPD
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Lung sound mapping and time‐expanded wave‐form analysis in pneumonia (Pn)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (subjects without lung disease)
Number of subjects: 95
Study: 2972848

Group type: EXPERIMENTAL
Intervention: Immediate PTCA
Number of subjects: 389

Group type: COMPARATOR
Intervention: Delayed PTCA (18-48 hours)
Number of subjects: 389
Study: 29728149

Group type: EXPERIMENTAL
Intervention: Mental Health First Aid training and staff peer support service
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (usual practice)
Number of subjects: 25
Study: 28938877

Group type: EXPERIMENTAL
Intervention: Glibenclamide (n=13)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Metformin and insulin (n=10)
Number of subjects: 23
Study: 24733715

Group type: EXPERIMENTAL
Intervention: Nocturnal oxygen therapy (NOT) at 3.0 l/min
Number of subjects: 51

Group type: COMPARATOR
Intervention: No nocturnal oxygen therapy (no NOT)
Number of subjects: 51
Study: 23149137

Group type: EXPERIMENTAL
Intervention: Algorithm A (optimal variation)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Algorithm A (original version)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Algorithm B (original version)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Algorithm B (variation)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Algorithm A and B (comparison)
Number of subjects: 195
Study: 21506190

Group type: EXPERIMENTAL
Intervention: Sage leaf extract (500 mg capsule every 8 hours for 2 months)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 19565667

Group type: EXPERIMENTAL
Intervention: Caudal neostigmine 2 microg.kg(‐1) with levobupivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Caudal neostigmine 4 microg.kg(‐1) with levobupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Caudal 0.25% levobupivacaine (1 ml.kg(‐1)) alone
Number of subjects: 60
Study: 17037712

Group type: EXPERIMENTAL
Intervention: Fennel extract
Number of subjects: 110

Group type: COMPARATOR
Intervention: Mefenamic acid
Number of subjects: 110
Study: 12622344

Group type: EXPERIMENTAL
Intervention: Lorazepam (2.0 mg/70 kg orally administered)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Scopolamine (0.6 mg/70 kg subcutaneously administered)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Scopolamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 10678601

Group type: EXPERIMENTAL
Intervention: Isometric biceps brachii contraction
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Neck flexion
Number of subjects: 12
Study: 9070565

Group type: EXPERIMENTAL
Intervention: Plasma total homocysteine levels
Number of subjects: 149
Study: 8463943

Group type: EXPERIMENTAL
Intervention: DL‐PLGA membrane placed over the roots and alveolar bone
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control teeth (no DL‐PLGA membrane)
Number of subjects: 17
Study: 3751450

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (Trental 400)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (protocol B, without hemorheologic treatment)
Number of subjects: 82
Study: 31683023

Group type: EXPERIMENTAL
Intervention: Conditioned Biofeedback
Number of subjects: 73

Group type: COMPARATOR
Intervention: Biofeedback Only
Number of subjects: 73

Group type: COMPARATOR
Intervention: Biofeedback+Shock
Number of subjects: 73
Study: 29846091

Group type: EXPERIMENTAL
Intervention: Melatonin (MEL) 10 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 10
Study: 28059034

Group type: EXPERIMENTAL
Intervention: Midazolam 2.5 mg and Haloperidol 2.5 mg (IM) plus Morphine 0.05 mg/kg (IV)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Distilled water 5 cc (IM) plus Morphine 0.05 mg/kg (IV)
Number of subjects: 87
Study: 25495494

Group type: EXPERIMENTAL
Intervention: Pedometer-determined physical activity measurement
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Mobility limitation (use of a cane or rollator)
Number of subjects: 149
Study: 22313740

Group type: EXPERIMENTAL
Intervention: Treadmill
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cycle ergometer
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Treadmill and Cycle ergometer
Number of subjects: 12
Study: 20660712

Group type: EXPERIMENTAL
Intervention: Humoral immune response to cryptic epitopes in patients with cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Detection of tumor antigens in cancer tissue arrays
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Potential markers for cancer diagnosis, prognosis, or therapy monitoring
Number of subjects: 0
Study: 18339487

Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiation therapy (IMRT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: IMRT with dose escalation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: IMRT with reduced PTV margin (3 mm)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Six-field conformal radiotherapy
Number of subjects: 20
Study: 15359247

Group type: EXPERIMENTAL
Intervention: Acrylic biprism (Tonosafe)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Silicone shield (Tonoshield)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard Goldmann applanation tonometer (GAT)
Number of subjects: 40
Study: 12433015

Group type: EXPERIMENTAL
Intervention: Expressive Writing (EW)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Neutral Writing (NW)
Number of subjects: 42
Study: 10488702

Group type: EXPERIMENTAL
Intervention: Blood transfusion and vasoactive drugs followed by sclerotherapy
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Injection sclerotherapy at diagnostic endoscopy
Number of subjects: 695

Group type: COMPARATOR
Intervention: Bleeding from other sources related to portal hypertension
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Active variceal bleeding at diagnostic endoscopy
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Early bleeding
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Bilirubin
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Encephalopathy
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Shorter interval to admission
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Log urea
Number of subjects: 695
Study: 9601759

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (1 mg/kg/day i.m. over 3 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 40
Study: 1827019

Group type: EXPERIMENTAL
Intervention: Isradipine 5 mg once daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6765546

Group type: EXPERIMENTAL
Intervention: Human insulin (recombinant DNA)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Purified porcine insulin (PPI)
Number of subjects: 7
Study: 30589984

Group type: EXPERIMENTAL
Intervention: Cytisine capsules (25-day supply)
Number of subjects: 1266

Group type: COMPARATOR
Intervention: Varenicline tablets (12-week supply)
Number of subjects: 1266
Study: 28095104

Group type: EXPERIMENTAL
Intervention: Water-based exercise (WB; n=15)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Land-based exercise (LB; n=14)
Number of subjects: 29
Study: 25596682

Group type: EXPERIMENTAL
Intervention: Everolimus plus exemestane
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo plus exemestane
Number of subjects: 106
Study: 23906000

Group type: EXPERIMENTAL
Intervention: Quality of education (indexed by irregular word reading skill)
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Test version
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Assessment site
Number of subjects: 385

Group type: COMPARATOR
Intervention: Ethnicity
Number of subjects: 385

Group type: COMPARATOR
Intervention: Years of total education
Number of subjects: 385
Study: 21427404

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (CTX)
Number of subjects: 541

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 541
Study: 18957828

Group type: EXPERIMENTAL
Intervention: Boron neutron capture therapy (BNCT)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Boron neutron capture therapy (BNCT) followed by X-ray treatment (XRT) of 20 to 30 Gy
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Boron neutron capture therapy (BNCT) (protocol 1 and 2 together)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Institutional historical controls
Number of subjects: 21
Study: 17188853

Group type: EXPERIMENTAL
Intervention: Interval training (3‐min intervals)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continuous training
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Interval training and Continuous training
Number of subjects: 60
Study: 15149351

Group type: EXPERIMENTAL
Intervention: High-flux hemodialysis
Number of subjects: 1846

Group type: COMPARATOR
Intervention: Standard-dose hemodialysis
Number of subjects: 1846

Group type: COMPARATOR
Intervention: Low-flux hemodialysis
Number of subjects: 1846

Group type: COMPARATOR
Intervention: High-dose hemodialysis
Number of subjects: 1846
Study: 12381087

Group type: EXPERIMENTAL
Intervention: Continuous ATP injection
Number of subjects: 14
Study: 10325874

Group type: EXPERIMENTAL
Intervention: Belladonna C30
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 7616871

Group type: EXPERIMENTAL
Intervention: Gynodian Depot cartridges (4 mg estradiovalerate and 200 mg prasteronenantate) given as muscular injection in 6-10 week intervals (mean 7 weeks +/- 4 days)
Number of subjects: 50
Study: 2654080

Group type: EXPERIMENTAL
Intervention: naftifin hydrochloride cream
Number of subjects: 19

Group type: COMPARATOR
Intervention: clotrimazole 1%
Number of subjects: 19

Group type: COMPARATOR
Intervention: clotrimazole 1% + hydrocortisone 1%
Number of subjects: 19

Group type: COMPARATOR
Intervention: hydrocortisone 0.5%
Number of subjects: 19

Group type: COMPARATOR
Intervention: hydrocortisone 1%
Number of subjects: 19

Group type: COMPARATOR
Intervention: hydrocortisone 2.5%
Number of subjects: 19
Study: 1009036

Group type: EXPERIMENTAL
Intervention: Ayre spatula
Number of subjects: 982

Group type: COMPARATOR
Intervention: Armovical spatula
Number of subjects: 982
Study: 31564288

Group type: EXPERIMENTAL
Intervention: Mandibular Advancement Device (MAD)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 59
Study: 26853601

Group type: EXPERIMENTAL
Intervention: Ancient khorasan wheat diet
Number of subjects: 21

Group type: COMPARATOR
Intervention: Modern control wheat diet
Number of subjects: 21
Study: 26486824

Group type: EXPERIMENTAL
Intervention: TAP‐144‐SR (6M) 22.5 mg
Number of subjects: 160

Group type: COMPARATOR
Intervention: TAP‐144‐SR (3M) 11.25 mg
Number of subjects: 160
Study: 24350515

Group type: EXPERIMENTAL
Intervention: Mobile bearing high flex knee arthroplasty
Number of subjects: 39

Group type: COMPARATOR
Intervention: Fixed bearing posterior stabilized knee (LPS)
Number of subjects: 39
Study: 21574291

Group type: EXPERIMENTAL
Intervention: Fixed combinations of corinetec and gyzaar supplemented by acupuncture reflexotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drug therapy without acupuncture
Number of subjects: 0
Study: 18824862

Group type: EXPERIMENTAL
Intervention: Dexibuprofen 200 mg
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Dexibuprofen 300 mg
Number of subjects: 102

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg
Number of subjects: 102
Study: 16710256

Group type: EXPERIMENTAL
Intervention: Eptifibatide (Integrilin) administered as two boluses of 180 mg/kg followed by infusion of 2 mg/kg per min for 24 hours and 1.3 mg/kg for 48 hours
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no GP IIb-IIIa antagonists used)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 25